" class="no-js "lang="en-US"> Hans Eriksson - Medtech Alert
Friday, January 17, 2025
Hans Eriksson

Hans Eriksson

About Hans Eriksson

Experienced drug developer and clinical psychiatrist with more than 20 years pharma industry background (UK, Denmark, Sweden, USA and Germany); working as a medical specialist in a global marketing organization, as marketing company medical director, as line manager within clinical development, as the global medical director for a major brand (Seroquel), as chief specialist within clinical development and as chief medical officer.

Specialties: Drug development. Medical affairs. Clinical psychiatry (e.g. mood and anxiety disorders, schizophrenia, emergency psychiatry).

Related Story

HMNC Brain Health and Develco Pharma Announce Promising Preliminary Results in Treatment-resistant Depression (TRD)

April 1 2022

HMNC Brain Health (“HMNC” or the “Company”), a global clinical stage biopharmaceutical company pioneering the […]